MAP2K7 and glioblastoma: In line with this, Sunayama et al. 8 established that cross-inhibitory modulation between Mek/Erk and PI3K/mTOR pathways regulates the maintenance of the self-renewal as well as the tumorigenic capacity of glioblastoma cancer stem-like cells.